NEW RESOURCES AND SURVEILLANCE GUIDES TO SUPPORT EARLY DETECTION OF PANCREATIC CANCER Pancare Foundation disseminates material commissioned by Cancer Australia and developed by UQ and Uni of Melbourne
With
Dr Michael KC Lee,
Medical Oncologist,
Peter MacCallum Cancer Centre
Dr Mark Buzza,
Head of Research, Innovation and Advocacy,
Pancare Foundation
SEGMENT
Filmed in Melbourne | February 2026
Pancreatic cancer remains one of Australia’s deadliest cancers, with five-year survival rates hovering at just 14%, with little improvement over several decades. Often called the ‘silent killer’, the disease frequently presents with minimal or vague symptoms, resulting in late diagnoses and poor outcomes. Pancare Foundation is leading the rollout of new clinical resources and surveillance guides to support healthcare professionals in identifying at-risk patients and promoting early detection.
More than 4,500 Australians are diagnosed with pancreatic cancer each year, and the disease is projected to become the second leading cause of cancer-related death by 2030. Despite advances in treatment, the lack of a population-level national screening program, as there is for bowel cancer for example, means that healthcare professionals play a critical role in early detection and patient education.
“Early identification is key,” said Dr Mark Buzza, Head of Research, Innovation and Advocacy, Pancare Foundation. “These new resources provide practical guidance for clinicians on risk assessment, surveillance protocols, and patient communication. By equipping healthcare professionals with the latest evidence-based tools, we can improve detection rates and ultimately patient outcomes.”
The resources highlight key risk factors to be aware of including a family history of pancreatic cancer, smoking, long-term diabetes, chronic pancreatitis, heavy alcohol use, and obesity.
Importantly, pancreatic cancer can also occur in patients without obvious risk factors. Developed by the University of Queensland (alongside their contributors), the new surveillance guides offer clear recommendations for monitoring high-risk individuals, identifying early symptoms, and coordinating referral pathways for diagnostic investigations.
In addition, the University of Melbourne provides pain and palliative care education resources for healthcare professionals, ensuring clinicians are equipped to support patients throughout the continuum of care.
Source: Adapted from Pancare Foundation media release
-
Breaking silos to transform women’s health through MedTech
In an interview with Australian Health Journal, Jasjit Baveja, Director of Regulatory and Industry Policy at the Medical Technology Association of Australia (MTAA), highlighted the growing importance of medical technology in addressing longstanding inequities in women’s health.
Drawing on the outcomes of the inaugural MTAA Women’s Health MedTech Summit, she explained how the event brought together clinicians, researchers, industry leaders, regulators, investors, government representatives and patient advocates to tackle complex challenges through a collaborative approach.
-
Redefining diversity in clinical trials
Ensuring inclusion, diversity, equity and patient input in the development of novel drugs and medical devices has become well accepted in health care. However appropriate implementation of these elements has been a challenge for many. Only by implementing these conscious inputs can patient outcomes be improved and health disparities in marginalised groups be addressed.
Australian Health Journal spoke to Gillian Mason, Consumer and Community Involvement Lead at Hunter Medical Research Institute in Newcastle, NSW on this topic discussed at the recent ARCS Conference in Sydney.
-
Reflections from the unstoppable giant in wound care
Professor Dr.Geoff Sussman holds a position in the Faculty of Medicine, Nursing and Health Sciences Monash University, and is the Adjunct Professor of Wound Care He is a wound consultant at the Wound Clinic Austin Hospital.
